(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 13.93% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Biote's revenue in 2024 is $185,360,000.On average, 5 Wall Street analysts forecast BTMD's revenue for 2024 to be $15,080,119,193, with the lowest BTMD revenue forecast at $14,921,217,912, and the highest BTMD revenue forecast at $15,246,175,504. On average, 5 Wall Street analysts forecast BTMD's revenue for 2025 to be $17,422,795,124, with the lowest BTMD revenue forecast at $16,784,506,862, and the highest BTMD revenue forecast at $18,632,889,500.
In 2026, BTMD is forecast to generate $20,762,256,112 in revenue, with the lowest revenue forecast at $19,015,981,708 and the highest revenue forecast at $22,508,530,516.